Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020Niklas Huntemann(University Hospital Münster), Sven G. Meuth(University of Würzburg)DrugsJune 1, 202110.1007/s40265-021-01526-wCited by 35SaveCiteExport RISWatch citationsRelated PapersBlood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells|Nature Communications|2016|122Cytotoxic CD8<sup>+</sup>T Cell–Neuron Interactions: Perforin-Dependent Electrical Silencing Precedes But Is Not Causally Linked to Neuronal Cell Death|Journal of Neuroscience|2009|89